Sugi Predict

Sugi Predict / Compounds / SCHEMBL22790967

SCHEMBL22790967

SCHEMBL22790967

C#CCC(N)C(=O)Nc1ccc(COc2ccc(-c3cc(C(F)(F)F)n(C)n3)c(O)c2-c2cncc(C(F)(F)F)c2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 2/20 0.33
▸ FYN P06241 2/20 0.33
▸ CSF1R P07333 2/20 0.33
▸ LYN P07948 2/20 0.33
▸ KIT P10721 2/20 0.33
▸ SRC P12931 2/20 0.33
▸ FLT1 P17948 2/20 0.33
▸ FLT4 P35916 2/20 0.33
▸ BLK P51451 2/20 0.33
▸ DYRK3 O43781 1/20 0.33
▸ JAK2 O60674 1/20 0.33
▸ ROCK2 O75116 1/20 0.33
▸ MAP4K4 O95819 1/20 0.33
▸ EGFR P00533 1/20 0.33
▸ NTRK1 P04629 1/20 0.33
▸ INSR P06213 1/20 0.33
▸ RET P07949 1/20 0.33
▸ MET P08581 1/20 0.33
▸ FGFR1 P11362 1/20 0.33
▸ FER P16591 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21786514 0.89 ROCK1 (0.31) ROCK1CTPS1
SCHEMBL22791004 0.88 CIT (0.33) LCKFYNCSF1RLYNKIT
SCHEMBL22791129 0.86 ALOX5 (0.32) PTGES
SCHEMBL21786493 0.81 PTGER1 (0.39) CYP2C9PTGER1PTGESHTR2AHTR2C
SCHEMBL22790968 0.79 CYP19A1 (0.39) METRAB9A
SCHEMBL21786516 0.77 CTPS1 (0.30) CTPS1
SCHEMBL21786438 0.76 — —
SCHEMBL22791329 0.74 MGAM (0.33) FYNDYRK3DYRK1APTGES
SCHEMBL21786489 0.74 AGER (0.35) FYNDYRK3DYRK1A
SCHEMBL21786535 0.73 THRB (0.36) PTGER1PTGESLRRK2SRPK3RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210395206-A1 SUBSTITUTED HETEROCYCLES AS c-MYC TARGETING AGENTS NORTHWESTERN UNIVERSITY 2021-12-23 — — US disclosed
US-11142504-B2 Substituted heterocycles as c-MYC targeting agents NORTHWESTERN UNIVERSITY (US) 2021-10-12 — — US disclosed
US-20200392116-A1 SUBSTITUTED HETEROCYCLES AS c-MYC TARGETING AGENTS NORTHWESTERN UNIVERSITY (US) 2020-12-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200392116-A1 SUBSTITUTED HETEROCYCLES AS c-MYC TARGETING AGENTS MYC, MYCBP, MYCBP2 LCK 1482/4885FYN 1678/4885CSF1R 2247/4885
US-20210395206-A1 SUBSTITUTED HETEROCYCLES AS c-MYC TARGETING AGENTS MYC, MYCBP, MYCBP2 LCK 1482/4885FYN 1678/4885CSF1R 2247/4885
US-11142504-B2 Substituted heterocycles as c-MYC targeting agents MYC, MYCBP, MYCBP2 LCK 1482/4885FYN 1678/4885CSF1R 2247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.